编辑推荐： 本研究首次在加蓬入侵物种黑家鼠 (Rattus rattus)中检测到啮齿类疟原虫Plasmodium yoelii，通过系统筛查527只农村地区捕获的啮齿动物，发现2例阳性样本 (0.38%)。研究采用分子生物学技术结合系统发育分析，证实其与当地原生啮齿动物携带的虫株高度同源，挑战了"啮齿类疟原虫仅限原生宿主"的 ...

Methods: To test this hypothesis, eight weeks old hypertensive BPH/2J and normotensive BPN/3J female mice (n=6) were first characterized for their RBC physiology and subsequently infected with ...

D. L. Medica, P. Sinnis, Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect. Immun. 73, 4363–4369 (2005).

A new nested polymerase chain reaction method very efficient in detecting Plasmodium and Haemoproteus infections from avian blood. Journal of Parasitology 90: 191-194.

Four rodent malaria species [P. berghei, Plasmodium chabaudi (subspecies chabaudi and adami), Plasmodium vinckei, and Plasmodium yoelii] have been isolated from wild African rodents and are currently ...

在东南亚的热带雨林中，一种名为诺氏疟原虫（Plasmodium knowlesi）的疟疾寄生虫正悄然成为公共卫生新威胁。这种原本在猕猴群体中传播的病原体，随着人类活动范围的扩大，通过蚊媒实现了跨物种传播，导致人兽共患病例激增。令人担忧的是，尽管猕猴作为自然宿主能有效控制感染，人类感染却 ...

Malaria articles from across Nature Portfolio Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases ...

Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin. Int J Gen Med. 2009; 2: 47-55.

Malaria research. Read the latest medical research on malaria, including new control methods and malaria treatments.

The plasmodium stage. Image credit: Steve Young There’s a lot we don’t know about slime mould Slime moulds are poorly studied everywhere but particularly here in Australia, despite the fact that we ...

Cerebral malaria is the most severe neurological complication of infection with Plasmodium falciparum malaria. It is a clinical syndrome characterized by coma and asexual forms of the parasite on ...

We utilized the Pandemic Response Box chemical library of the Medicines for Malaria Venture, launched in 2019, to identify inhibitors with stage-specific potency and phenotypic signatures against the ...